One of the key factors to succeed in stock markets is to stay ahead and follow the trend as “Trend is the King”. Based on this belief, I added Caplin Point stock to portfolio few weeks back and now it has given more than 100% profits. The best part is it has still managed to continue its rally. Another good move on part of this pharma company is that it has tied up with a leading global pharmaceutical company Fresenius Kabi USA, LLC by entering into a mutual licensing and distribution agreement. As part of this agreement, Caplin Point Labs would be responsible for development and manufacturing of identified parenteral products. On the other hand, Fresenius Kabi USA would be holding these ANDAs as well as commercialize them in USA.
Based on the above news, the Caplin Point share price rose almost 5% today (as on 6th April’2015). This proves that once you invest in good stocks that are trending, you increase the chances of enjoying plenty of rallies in the same. Eventually, your belief would be rewarded with lots of things working in favor of the company. The tie-up with a leading pharma player like Fresenius is a big thing for Caplin Labs. The agreement is product specific for USA and the contract features two products as of now. Milestone payments for 2 products have already been received by Caplin Point company and the product development cum dossier preparation has just begun.
It would be interesting to see the future trend in Caplin Point Labs following such positive activities. One thing is for sure, our patience with this stock has rewarded big gains. If we keep up with the trend, good news would follow the stocks in which we invest. Keep minting always and enjoy the money rain..hahahaha!
NOTE: The above information is purely my own personal take / view / discussion on Caplin Point stock after my analysis along with the news published in the source website mentioned above. I am not at all a certified Stock Analyst or Stock Broker or Research Analyst. All my readers of this blog are advised to perform their own analysis and consult any authorized research analyst or financial advisor before taking their investment decision.
Note: To get the best benefits about regular updates related to various articles, motivational thoughts and contests posted on this blog, you can subscribe to our email newsletter service below: